Alós-Almiñana M - Search Results

1

Pharmacokinetic/Pharmacodynamic Analysis of Voriconazole Against Candida spp. and Aspergillus spp. in Allogeneic Stem Cell Transplant Recipients.

Perez-Pitarch A, Guglieri-Lopez B, Ferriols-Lisart R, Pérez A, Ezquer-Garín C, Hernández-Boluda JC, Piñana JL, Navarro D, Solano C, Alós-Almiñana M. Perez-Pitarch A, et al. Among authors: alos alminana m. Ther Drug Monit. 2019 Dec;41(6):740-747. doi: 10.1097/FTD.0000000000000657. Ther Drug Monit. 2019. PMID: 31136417

2

Effectiveness and safety of once-daily aminoglycosides: a meta-analysis.

Ferriols-Lisart R, Alós-Almiñana M. Ferriols-Lisart R, et al. Am J Health Syst Pharm. 1996 May 15;53(10):1141-50. doi: 10.1093/ajhp/53.10.1141. Am J Health Syst Pharm. 1996. PMID: 8734674

3

[Design and validation of a dosing algorithm for vancomycin in premature neonates].

Juan Aguilar M, Ferriols Lisart R, Tosca Segura R, Alós Almiñana M. Juan Aguilar M, et al. An Pediatr (Barc). 2008 Feb;68(2):117-23. doi: 10.1157/13116225. An Pediatr (Barc). 2008. PMID: 18341876 Free article. Spanish.

4

Comparing the digoxin test with the Architect® i1000sr system with respect to the AxSYM® system.

Albert Vicent E, Ferriols Lisart R, Roch Ventura MA, Alós Almiñana M. Albert Vicent E, et al. Farm Hosp. 2011 Sep-Oct;35(5):256-9. doi: 10.1016/j.farma.2011.02.001. Epub 2011 Apr 22. Farm Hosp. 2011. PMID: 21514866 Free article. English, Spanish.

5

A pharmacokinetic approach to model-guided design of infliximab schedules in ulcerative colitis patients.

Pérez-Pitarch A, Ferriols-Lisart R, Alós-Almiñana M, Mínguez-Pérez M. Pérez-Pitarch A, et al. Rev Esp Enferm Dig. 2015 Mar;107(3):137-42. Rev Esp Enferm Dig. 2015. PMID: 25733037 Free article.

6

Effectiveness, toxicity, and economic evaluation of vinflunine for the treatment of patients with transitional cell carcinoma in the Spanish outpatient setting.

Guglieri-López B, Pérez-Pitarch A, Porta-Oltra B, Ferriols-Lisart F, Climente-Martí M, Alós-Almiñana M. Guglieri-López B, et al. Anticancer Drugs. 2015 Sep;26(8):860-5. doi: 10.1097/CAD.0000000000000240. Anticancer Drugs. 2015. PMID: 25919319

7

Stability of tacrolimus ophthalmic solution.

Ezquer-Garin C, Ferriols-Lisart R, Alós-Almiñana M. Ezquer-Garin C, et al. Am J Health Syst Pharm. 2017 Jul 1;74(13):1002-1006. doi: 10.2146/ajhp160169. Am J Health Syst Pharm. 2017. PMID: 28645998

8

Validated HPLC-UV detection method for the simultaneous determination of ceftolozane and tazobactam in human plasma.

Ezquer-Garin C, Ferriols-Lisart R, Alós-Almiñana M, Aguilar-Aguilar G, Belda-Nacher JF, Carbonell JA. Ezquer-Garin C, et al. Among authors: alos alminana m. Bioanalysis. 2018 Apr 1;10(7):461-473. doi: 10.4155/bio-2017-0257. Epub 2018 Apr 10. Bioanalysis. 2018. PMID: 29633862

9

Stability of mycophenolate mofetil in polypropylene 5% dextrose infusion bags and chemical compatibility associated with the use of the Equashield^® closed-system transfer device.

Ezquer-Garin C, Ferriols-Lisart R, Alós-Almiñana M. Ezquer-Garin C, et al. Among authors: alos alminana m. Biomed Chromatogr. 2019 Jul;33(7):e4529. doi: 10.1002/bmc.4529. Epub 2019 Mar 24. Biomed Chromatogr. 2019. PMID: 30845352

10

Stability of tedizolid phosphate-sodium rifampicin and tedizolid phosphate-meropenem admixtures in intravenous infusion bags stored at different temperatures.

Ezquer-Garin C, Ferriols-Lisart R, Martinez-López LM, Sangrador-Pelluz C, Nicolás-Picó J, Alós-Almiñana M. Ezquer-Garin C, et al. Among authors: alos alminana m. Pharmazie. 2020 May 1;75(5):172-176. doi: 10.1691/ph.2020.9155. Pharmazie. 2020. PMID: 32393422

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters